Unaudited condensed Group statement of cash flows
Download (EXCEL) |
Six months ended 30 November 2017 Unaudited R'000 |
Six months ended 30 November 2016 Unaudited R'000 |
Year ended 31 May 2017 Audited R'000 |
|||||
---|---|---|---|---|---|---|---|
Cash generated by operations | 3 297 462 | 945 583 | 1 753 991 | ||||
Interest received | 43 702 | 25 693 | 52 300 | ||||
Interest paid | (40 642) | (65 819) | (105 518) | ||||
Taxation paid | (184 522) | (196 074) | (338 814) | ||||
Net cash generated from operating activities | 3 116 000 | 709 383 | 1 361 959 | ||||
Cash flows from investing activities | |||||||
Acquisition of intangible assets and property, plant and equipment | (46 119) | (83 530) | (113 280) | ||||
Acquisition of subsidiaries net of cash acquired | – | 771 | – | ||||
Acquisition of associate | (5 500 000) | (7 530) | – | ||||
Acquisition of bond notes | (79 050) | – | – | ||||
Loans advanced to Cell C | (740 000) | – | – | ||||
Capital contribution to Oxigen Services India | – | – | (25 534) | ||||
Equity loans advanced to Lornanox | (883) | (1 758) | (5 875) | ||||
Loans repaid/(granted) | 66 567 | (73 889) | (117 268) | ||||
Loans granted to associates and joint ventures | (1 841) | (3 401) | (15 756) | ||||
Settlement of contingent consideration | (27 868) | (49 109) | (50 666) | ||||
Contingent proceeds received | – | – | 12 839 | ||||
Other investing activities | (16 519) | 11 544 | (4 936) | ||||
Net cash utilised in investing activities | (6 345 713) | (206 902) | (320 476) | ||||
Cash flows from financing activities | |||||||
Acquisition of treasury shares | (28 846) | (7 381) | (7 381) | ||||
Proceeds on share issue | 2 750 000* | – | – | ||||
Dividends paid to non-controlling interest | (21 100) | (6 600) | (26 788) | ||||
Dividends paid to equity holders of the parent | (349 804) | (242 823) | (242 823) | ||||
Other financing activities | – | (2 803) | (2 803) | ||||
Net cash generated from/(utilised in) financing activities | 2 350 250 | (259 607) | (279 795) | ||||
Net (decrease)/increase in cash and cash equivalents | (879 463) | 242 874 | 761 688 | ||||
Cash and cash equivalents at the beginning of the period | 1 350 666 | 589 027 | 589 027 | ||||
Exchange gains on cash and cash equivalents | – | (36) | (49) | ||||
Cash and cash equivalents at the end of the period | 471 203 | 831 865 | 1 350 666 |
* | Shares to the value of R3.03 billion were issued by Blue Label in the current period. Of this amount R2.75 billion was received in cash. The balance of R283 million was issued in exchange for shares in 3G Mobile. |